Factors which influence the levels of ST-2, Galectin-3 and MMP-9 in Acute Coronary Syndrome.

CONCLUSION: High Galectin-3, MMP-9, and ST-2 are independently influenced to a certain degree by demographic, clinical and laboratory characteristics. However, no single characteristic was found to be commonly associated with all of the three biomarkers. PMID: 31438834 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research

Related Links:

Abstract: The US industrial revolution led to a significant increase in the amount of dietary sugar consumed annually. The impact has become a public health crisis over the past several decades. The consequences are seen in the dramatic rise in rates of obesity, type 2 diabetes mellitus, and cardiovascular disease.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: SUGAR CONSUMPTION Source Type: research
The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like peptide (GLP-1) approved for use in the United States. Before Rybelsus, the drug had to be injected.
Source: WebMD Health - Category: Consumer Health News Source Type: news
The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s): Elizabeth Sellers
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
When it came to the cause of death, vitamin D levels were most clearly linked to deaths from diabetes complications.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Drugs & Pharmacology | Endocrinology | Heart | Hematology | Laboratory Medicine | Statistics | Study